Gabriella Pogorzelski

Gabriella Pogorzelski

Auto-generated profile, based on publicly available information

Gabriella Pogorzelski

Pulmonology Department, Sírio Libanês Hospital, São Paulo, SP, Brazil; Division of Pulmonology, Instituto do Coração (Incor), Hospital Das Clínicas HC-FMUSP, Faculdade De Medicina, Universidade De São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2026 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
ACAnita Cortez
Anita Cortez
MSMaria Cristina Nunez Seiwald
Maria Cristina Nunez Seiwald
AFAna Rita Brito Medeiros da Fonseca
Ana Rita Brito Medeiros da Fonseca
AFAliana Meneses Ferreira
Aliana Meneses Ferreira
GPGabriella Pogorzelski
Gabriella Pogorzelski
ACAndré Nathan Costa
André Nathan Costa
Allogeneic bone marrow transplantation can lead to various pulmonary complications, including acute fibrinous organizing pneumonia. This condition is rare and presents with aggressive clinical features, distinct from other forms of organizing pneumonia, such as cryptogenic organizing pneumonia. A literature review using the PubMed, Embase, Lilacs, and Cochrane databases was conducted to analyze cases of acute fibrinous organizing pneumonia following transplantation focusing on clinical features, therapeutic approaches, and outcomes. The case of a 62-year-old female who developed acute fibrinous organizing pneumonia after transplantation for acute myeloid leukemia is presented. Despite an initial absence of infectious agents, parainfluenza virus was later identified in a bronchoalveolar lavage. The patient progressed to severe hypoxemic respiratory failure and was unresponsive to corticosteroids and rituximab, ultimately dying seven months post-transplant. This is a rare and severe complication following allogeneic bone marrow transplantation. Early diagnosis, histopathological confirmation, and prompt initiation of corticosteroid therapy are critical for improving outcomes. Patients diagnosed before Day +100 generally have a better response to treatment and more favorable clinical outcomes. The need for a more effective and targeted treatment strategy remains an unmet challenge in managing this condition.